Dr Kevin Tay

Dr Kevin Tay is a Senior Consultant Medical Oncologist with the OncoCare Cancer Centre and also a Visiting Consultant at the National Cancer Center Singapore. His subspecialty interests are in women-related cancers such as breast cancers & gynaecological cancers, melanoma, brain cancers, soft tissue & bone sarcomas, and also hematological malignancies such as lymphoma, multiple myeloma, leukemia, cancer in HIV people. He has more than 25 years of clinical practice.

Dr Tay received his medical degree from the National University of Singapore, School of Medicine and did his post-graduate training in Internal Medicine at the University of Hawaii and his Medical Oncology fellowship at the National Cancer Institute (NCI), National Institute of Health (NIH) in USA. Dr. Tay was also appointed Chief Resident and Chief Fellow during both his residency and fellowship programs respectively. 

During his time at the National Cancer Institute (NCI) and the National Institute of Health (NIH) in the USA, Dr Tay trained under several renowned oncologists, including Dr Sandy Swain, a world expert on breast cancer and the previous President of the American Society of Clinical Oncology, and Dr Giuseppe Giaccone, the previous Chair of the EORTC’s Lung Cancer Cooperative Group and also the Associate Director for Clinical Research at the Lombardi Comprehensive Cancer Center, Georgetown University. Dr Tay also spent two years doing research at the NIH with an internationally renowned translational research group, under the mentorship of Dr Wyndham Wilson, Dr Louis Staudt, and Dr Elaine Jaffe.

Upon returning to Singapore in early 2010, Dr Tay joined the Department of Medical Oncology at the National Cancer Center. He continued to be active in translational research and is part of the core group at the National Cancer Center Singapore. He was recognized as one of the top cancer doctors doing research and was awarded the prestigious center grant by the National Medical Research Council of Singapore.

Dr Tay currently holds American Board certifications for the practice of Internal Medicine and Medical Oncology. 

Dr Tay is actively collaborating with other leading Asian researchers from Korea, Taiwan, and Hong Kong as well as with his former colleagues at the National Institute of Health in the USA in genomic oncology research. Dr Tay has also published widely in numerous journals, including Nature Genetics, the Journal of Clinical Oncology, The Lancet Hematology, American Journal of Medicine, Leukemia & Lymphoma, and Seminars in Hematology.

Dr Kevin Tay is proficient in English, Mandarin, Hokkien, and Cantonese.